Literature DB >> 33603957

Dihydroorotate Dehydrogenase Inhibitors for Treating Acute Myelogenous Leukemia (AML).

Ram W Sabnis1.   

Abstract

Entities:  

Year:  2021        PMID： 33603957      PMCID： PMC7883377          DOI： 10.1021/acsmedchemlett.0c00669

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN： 1948-5875            Impact factor:   4.345


× No keyword cloud information.
  4 in total

Review 1.  Therapeutic and Diagnostic Implications of T Cell Scarring in Celiac Disease and Beyond.

Authors:  Asbjørn Christophersen; Louise F Risnes; Shiva Dahal-Koirala; Ludvig M Sollid
Journal:  Trends Mol Med       Date:  2019-07-19       Impact factor: 11.951

Review 2.  Metabolomics in acute myeloid leukemia.

Authors:  Anna V Wojcicki; Maya M Kasowski; Kathleen M Sakamoto; Norman Lacayo
Journal:  Mol Genet Metab       Date:  2020-05-18       Impact factor: 4.797

Review 3.  Dihydroorotate dehydrogenase in oxidative phosphorylation and cancer.

Authors:  Stepana Boukalova; Sona Hubackova; Mirko Milosevic; Zuzana Ezrova; Jiri Neuzil; Jakub Rohlena
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2020-03-06       Impact factor: 5.187

Review 4.  Revisiting the role of dihydroorotate dehydrogenase as a therapeutic target for cancer.

Authors:  Joseph T Madak; Armand Bankhead; Christine R Cuthbertson; Hollis D Showalter; Nouri Neamati
Journal:  Pharmacol Ther       Date:  2018-10-19       Impact factor: 12.310
  4 in total
  1 in total

1.  Targeting Acute Myelogenous Leukemia Using Potent Human Dihydroorotate Dehydrogenase Inhibitors Based on the 2-Hydroxypyrazolo[1,5-a]pyridine Scaffold: SAR of the Aryloxyaryl Moiety.

Authors:  Stefano Sainas; Marta Giorgis; Paola Circosta; Giulio Poli; Marta Alberti; Alice Passoni; Valentina Gaidano; Agnese C Pippione; Nicoletta Vitale; Davide Bonanni; Barbara Rolando; Alessandro Cignetti; Cristina Ramondetti; Alessia Lanno; Davide M Ferraris; Barbara Canepa; Barbara Buccinnà; Marco Piccinini; Menico Rizzi; Giuseppe Saglio; Salam Al-Karadaghi; Donatella Boschi; Riccardo Miggiano; Tiziano Tuccinardi; Marco L Lolli
Journal:  J Med Chem       Date:  2022-09-26       Impact factor: 8.039
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.